Is renal Na(+),K(+)-ATPase a new target for renin–angiotensin blocking agents in diabetic nephropathy?

Autor Rossing, Peter
Vydáno 2008

Mineralocorticoid Receptor Antagonists for Diabetic Kidney Disease

Autor Rossing, Peter
Vydáno v Clin J Am Soc Nephrol (2020)

Successful glucose lowering therapy triumphs in heart failure

Autor Rossing, Peter
Vydáno v EClinicalMedicine (2021)

Can ADAMTS13 Lead Us to the Paradise of Personalized Medicine?

Autor Rossing, Peter, Lajer, Maria
Vydáno 2013

Diagnosis of diabetic kidney disease: state of the art and future perspective

Autor Persson, Frederik, Rossing, Peter
Vydáno v Kidney Int Suppl (2011) (2018)

A narrative review of new treatment options for chronic kidney disease in type 2 diabetes

Autor Persson, Frederik, Borg, Rikke, Rossing, Peter
Vydáno v Ann Transl Med (2021)

Direct renin inhibition in chronic kidney disease

Autor Persson, Frederik, Rossing, Peter, Parving, Hans-Henrik
Vydáno 2013

Inflammation Leads the Way on the ROADMAP to Diabetic Kidney Disease

Autor Persson, Frederik, Frimodt-Møller, Marie, Rossing, Peter
Vydáno v Kidney Int Rep (2019)

Mitigating risk of aldosterone in diabetic kidney disease

Autor Frimodt-Møller, Marie, Persson, Frederik, Rossing, Peter
Vydáno v Curr Opin Nephrol Hypertens (2020)

Concomitant diabetes with atrial fibrillation and anticoagulation management considerations

Autor Kreutz, Reinhold, Camm, A John, Rossing, Peter
Vydáno v Eur Heart J Suppl (2020)

Fast renal decline to ESRD: an unrecognized feature of nephropathy in diabetes

Autor Krolewski, Andrzej S., Skupien, Jan, Rossing, Peter, Warram, James H.
Vydáno v Kidney Int (2017)

Prevention of microalbuminuria using early intervention with renin-angiotensin system inhibitors in patients with type 2 diabetes: A systematic review

Autor Persson, Frederik, Lindhardt, Morten, Rossing, Peter, Parving, Hans-Henrik
Vydáno v J Renin Angiotensin Aldosterone Syst (2016)

Editorial: Novel Biomarkers for Type 2 Diabetes

Autor Ahluwalia, Tarunveer S., Kilpeläinen, Tuomas O., Singh, Sandeep, Rossing, Peter
Vydáno v Front Endocrinol (Lausanne) (2019)

Metformin and cardiorenal outcomes in diabetes: A reappraisal

Autor Petrie, John R., Rossing, Peter R., Campbell, Ian W.
Vydáno v Diabetes Obes Metab (2020)

Arterial Stiffness Is Associated With Cardiovascular, Renal, Retinal, and Autonomic Disease in Type 1 Diabetes

Autor Theilade, Simone, Lajer, Maria, Persson, Frederik, Joergensen, Christel, Rossing, Peter
Vydáno 2013

Urinary Alpha- and Pi-Glutathione S-Transferases in Adult Patients with Type 1 Diabetes

Autor von Scholten, Bernt Johan, Theilade, Simone, Lajer, Maria, Rossing, Peter
Vydáno 2014

Linking Kidney and Cardiovascular Complications in Diabetes—Impact on Prognostication and Treatment: The 2019 Edwin Bierman Award Lecture

Autor Rossing, Peter, Persson, Frederik, Frimodt-Møller, Marie, Hansen, Tine Willum
Vydáno v Diabetes (2021)

Discrepancy Between Tonometric Ambulatory and Cuff‐Based Office Blood Pressure Measurements in Patients With Type 1 Diabetes

Autor Theilade, Simone, Lajer, Maria, Joergensen, Christel, Persson, Frederik, Rossing, Peter
Vydáno v J Clin Hypertens (Greenwich) (2012)

YKL-40, a Marker of Inflammation and Endothelial Dysfunction, Is Elevated in Patients With Type 1 Diabetes and Increases With Levels of Albuminuria

Autor Rathcke, Camilla Noelle, Persson, Frederik, Tarnow, Lise, Rossing, Peter, Vestergaard, Henrik
Vydáno 2009

Plasma Growth Differentiation Factor-15 Independently Predicts All-Cause and Cardiovascular Mortality As Well As Deterioration of Kidney Function in Type 1 Diabetic Patients With N...

Autor Lajer, Maria, Jorsal, Anders, Tarnow, Lise, Parving, Hans-Henrik, Rossing, Peter
Vydáno 2010